中國創意控股(08368.HK)中期收入減少48.4%至2030萬元
格隆匯 8 月 7日丨中國創意控股(08368.HK)發佈公告,截至2020年6月30日止六個月,集團錄得約人民幣2030萬元的收入,較2019年同期減少約48.4%。收入來自節目製作,移動直播和電子商務以及藝人經紀業務。收入減少主要由於新型冠狀病毒大流行影響下,娛樂行業於年初時段停止運作而節目製作業務洽談授出連續劇播放權工作遞延,及演唱會沒能於全球限聚令下舉行。
報告期內,錄得約人民幣1060萬元的毛利,而2019年同期則錄得約人民幣1430萬元減少約25.9%。毛利率由去年同期36.3%增加至52.1%。期內的毛利主要由多項策劃、網上推廣宣傳活動及為合約藝人安排的廣告工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.